Users report 'no healthy upstream' error
Upstream Bio has swollen its IPO to $255 million as the company joins CAMP4 Therapeutics this morning in becoming the latest ...
According to the National Survey on Drug Use & Health, 16% of the United States population met the criteria for a substance ...
This week on "Podnosis," Fierce Healthcare's Emma Beavins chats with Healthy.io CEO Geoff Martin about how his company is ...
Some observers suspect that the number of baby eels migrating up Maine rivers is declining. Passamaquoddy fishermen have ...
RNA biotech CAMP4 Therapeutics has marked out plans for a $67 million IPO, with inflammation-focused Upstream Bio pegging its ...
Even with lower commodity prices, producers have maintained healthy shareholder returns through dividends and buybacks thanks ...
How did we get to this point of crisis with housing affordability? What are some of the obstacles to resolving the problems?
Global Upstream Bioprocessing Market is valued at approximately USD 9.54 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 9.72% over the forecast period 2024-2032.